Form EFFECT Nuvectis Pharma, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 20, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RetinaClear Flags Counterfeit Concerns After Review of 1,842 Support Cases
- InstaStoryViewer Expands Its Educational Content on Public Instagram Stories, Highlights and Responsible Media Access
- BNB Price Prediction: A $1,000 Target Meets Remittix’s $0.46 Final Presale Price
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share